RU2003107921A - SELECTIVE CYCLOPEPTIDES - Google Patents
SELECTIVE CYCLOPEPTIDESInfo
- Publication number
- RU2003107921A RU2003107921A RU2003107921/04A RU2003107921A RU2003107921A RU 2003107921 A RU2003107921 A RU 2003107921A RU 2003107921/04 A RU2003107921/04 A RU 2003107921/04A RU 2003107921 A RU2003107921 A RU 2003107921A RU 2003107921 A RU2003107921 A RU 2003107921A
- Authority
- RU
- Russia
- Prior art keywords
- lys
- asp
- hydrogen atom
- cyclo
- phe
- Prior art date
Links
- 102000001189 Cyclic Peptides Human genes 0.000 title 1
- 108010069514 Cyclic Peptides Proteins 0.000 title 1
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 59
- 150000001875 compounds Chemical class 0.000 claims 49
- 125000004432 carbon atoms Chemical group C* 0.000 claims 37
- OAMLVOVXNKILLQ-BQBZGAKWSA-N Asp-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(O)=O OAMLVOVXNKILLQ-BQBZGAKWSA-N 0.000 claims 35
- 108010092854 aspartyllysine Proteins 0.000 claims 35
- 125000000217 alkyl group Chemical group 0.000 claims 34
- 125000005843 halogen group Chemical group 0.000 claims 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 7
- 125000003342 alkenyl group Chemical group 0.000 claims 5
- 125000000304 alkynyl group Chemical group 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- 239000011780 sodium chloride Substances 0.000 claims 5
- 201000010099 disease Diseases 0.000 claims 4
- OABOXRPGTFRBFZ-IMJSIDKUSA-N (2R)-2-[[(2R)-2-amino-3-sulfanylpropanoyl]amino]-3-sulfanylpropanoic acid Chemical compound SC[C@H](N)C(=O)N[C@@H](CS)C(O)=O OABOXRPGTFRBFZ-IMJSIDKUSA-N 0.000 claims 3
- 102000001796 Melanocortin 4 receptor Human genes 0.000 claims 3
- 108010021436 Type 4 Melanocortin Receptor Proteins 0.000 claims 3
- 125000003545 alkoxy group Chemical group 0.000 claims 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims 3
- 108010004073 cysteinylcysteine Proteins 0.000 claims 3
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 3
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- BBBXWRGITSUJPB-YUMQZZPRSA-N Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O BBBXWRGITSUJPB-YUMQZZPRSA-N 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 238000005755 formation reaction Methods 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 0 CNC(C(*)NC(*)=O)=O Chemical compound CNC(C(*)NC(*)=O)=O 0.000 description 2
- ZMXIYERNXPIYFR-UHFFFAOYSA-N CCc1c(cccc2)c2ccc1 Chemical compound CCc1c(cccc2)c2ccc1 ZMXIYERNXPIYFR-UHFFFAOYSA-N 0.000 description 1
Claims (50)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22918400P | 2000-08-30 | 2000-08-30 | |
US60/229,184 | 2000-08-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2003107921A true RU2003107921A (en) | 2004-10-10 |
RU2239642C1 RU2239642C1 (en) | 2004-11-10 |
Family
ID=22860145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2003107921/04A RU2239642C1 (en) | 2000-08-30 | 2001-08-21 | Selective cyclopeptides |
Country Status (35)
Country | Link |
---|---|
US (1) | US7045591B2 (en) |
EP (1) | EP1315750B1 (en) |
JP (1) | JP4217069B2 (en) |
KR (1) | KR100483300B1 (en) |
CN (1) | CN100491396C (en) |
AR (2) | AR030504A1 (en) |
AT (1) | ATE353918T1 (en) |
AU (2) | AU8402601A (en) |
BR (1) | BR0113637A (en) |
CA (1) | CA2420058C (en) |
CY (1) | CY1106562T1 (en) |
CZ (1) | CZ2003584A3 (en) |
DE (1) | DE60126624T2 (en) |
DK (1) | DK1315750T3 (en) |
EC (1) | ECSP034503A (en) |
ES (1) | ES2280393T3 (en) |
HR (1) | HRP20030126B1 (en) |
HU (1) | HUP0303078A3 (en) |
IL (2) | IL154575A0 (en) |
JO (1) | JO2454B1 (en) |
MA (1) | MA27681A1 (en) |
MX (1) | MXPA03001721A (en) |
MY (1) | MY137457A (en) |
NO (1) | NO20030916L (en) |
NZ (1) | NZ523989A (en) |
PA (1) | PA8527201A1 (en) |
PE (1) | PE20020483A1 (en) |
PL (1) | PL366630A1 (en) |
PT (1) | PT1315750E (en) |
RU (1) | RU2239642C1 (en) |
SI (1) | SI1315750T1 (en) |
TW (1) | TWI248941B (en) |
WO (1) | WO2002018437A2 (en) |
YU (1) | YU15603A (en) |
ZA (1) | ZA200301015B (en) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6960646B2 (en) * | 2001-07-12 | 2005-11-01 | Merck & Co., Inc. | Cyclic peptides as potent and selective melanocortin-4 receptors agonists |
CA2462200A1 (en) | 2001-08-10 | 2003-02-20 | Palatin Technologies, Inc. | Peptidomimetics of biologically active metallopeptides |
US7456184B2 (en) * | 2003-05-01 | 2008-11-25 | Palatin Technologies Inc. | Melanocortin receptor-specific compounds |
US7732451B2 (en) | 2001-08-10 | 2010-06-08 | Palatin Technologies, Inc. | Naphthalene-containing melanocortin receptor-specific small molecule |
US7718802B2 (en) | 2001-08-10 | 2010-05-18 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific piperazine compounds |
US7655658B2 (en) | 2001-08-10 | 2010-02-02 | Palatin Technologies, Inc. | Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds |
US7354923B2 (en) * | 2001-08-10 | 2008-04-08 | Palatin Technologies, Inc. | Piperazine melanocortin-specific compounds |
AU2003248888A1 (en) | 2002-07-09 | 2004-01-23 | Palatin Technologies, Inc. | Peptide composition for treatment of sexual dysfunction |
US7968548B2 (en) | 2003-05-01 | 2011-06-28 | Palatin Technologies, Inc. | Melanocortin receptor-specific piperazine compounds with diamine groups |
US7727990B2 (en) | 2003-05-01 | 2010-06-01 | Palatin Technologies, Inc. | Melanocortin receptor-specific piperazine and keto-piperazine compounds |
US7727991B2 (en) | 2003-05-01 | 2010-06-01 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific single acyl piperazine compounds |
KR20060026011A (en) | 2003-05-09 | 2006-03-22 | 노보 노르디스크 에이/에스 | Peptides for use in treating obesity |
JP2007524584A (en) * | 2003-05-09 | 2007-08-30 | ノボ ノルディスク アクティーゼルスカブ | Peptides used to treat obesity |
WO2005000339A2 (en) * | 2003-06-19 | 2005-01-06 | Eli Lilly And Company | Melanocortin receptor 4(mc4) agonists and their uses |
WO2005000338A1 (en) * | 2003-06-19 | 2005-01-06 | Eli Lilly And Company | Uses of melanocortin-3 receptor (mc3r) agonist peptides |
US7084111B2 (en) | 2003-06-23 | 2006-08-01 | University Of Florida Research Foundation, Inc. | Melanocortin receptor templates, peptides, and use thereof |
RU2381233C2 (en) * | 2003-09-30 | 2010-02-10 | Ново Нордиск А/С | Melanocortin receptor agonists |
US7550602B1 (en) | 2004-01-14 | 2009-06-23 | Palatin Technologies, Inc. | Small molecule compositions for sexual dysfunction |
US6974187B2 (en) * | 2004-01-28 | 2005-12-13 | Tachi-S Co., Ltd. | Vehicle seat structure |
US20070123453A1 (en) * | 2004-03-29 | 2007-05-31 | Heiman Mark L | Uses of melanocortin-4 receptor (mc4r) agonist peptides administered by continuous infusion |
DE602005026380D1 (en) * | 2004-04-08 | 2011-03-31 | Astellas Pharma Inc | CONNECTION WS727713 |
US7709484B1 (en) | 2004-04-19 | 2010-05-04 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific piperazine compounds |
CN101052648A (en) * | 2004-11-04 | 2007-10-10 | 诺和诺德公司 | Novel peptide for treating obesity |
EP1812471A2 (en) * | 2004-11-04 | 2007-08-01 | Novo Nordisk A/S | Peptides for use in treating of obesity |
US20080306008A1 (en) * | 2004-11-04 | 2008-12-11 | Nova Nordisk A/S | Peptides for Use in the Treatment of Obesity |
EP1809666A2 (en) * | 2004-11-04 | 2007-07-25 | Novo Nordisk A/S | Peptides for use in the treating obesity |
KR20080027246A (en) * | 2005-05-31 | 2008-03-26 | 이섬 리서치 디벨러프먼트 컴파니 오브 더 히브루 유니버시티 오브 예루살렘 | BACKBONE CYCLIZED MELANOCORTIN STIMULATING HORMONE (alpha;MSH) ANALOGA |
EP1893240A2 (en) * | 2005-06-13 | 2008-03-05 | Nastech Pharmaceutical Company Inc. | Transmucosal delivery of peptide derivatives |
US20080015304A1 (en) | 2006-07-13 | 2008-01-17 | Klaus Hintzer | Aqueous emulsion polymerization process for producing fluoropolymers |
US7795332B2 (en) * | 2005-07-15 | 2010-09-14 | 3M Innovative Properties Company | Method of removing fluorinated carboxylic acid from aqueous liquid |
GB2430437A (en) * | 2005-09-27 | 2007-03-28 | 3M Innovative Properties Co | Method of making a fluoropolymer |
US7834017B2 (en) | 2006-08-11 | 2010-11-16 | Palatin Technologies, Inc. | Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents |
JP2010514728A (en) * | 2006-12-29 | 2010-05-06 | エフ.ホフマン−ラ ロシュ アーゲー | Synthesis method of cyclic peptide |
WO2008101137A1 (en) * | 2007-02-16 | 2008-08-21 | 3M Innovative Properties Company | System and process for the removal of fluorochemicals from water |
US20080264864A1 (en) | 2007-04-27 | 2008-10-30 | 3M Innovative Properties Company | PROCESS FOR REMOVING FLUORINATED EMULSIFIER FROM FLUOROPOLMER DISPERSIONS USING AN ANION-EXCHANGE RESIN AND A pH-DEPENDENT SURFACTANT AND FLUOROPOLYMER DISPERSIONS CONTAINING A pH-DEPENDENT SURFACTANT |
CA2689016C (en) * | 2007-05-25 | 2014-08-12 | Ipsen Pharma S.A.S. | Melanocortin receptor ligands modified with hydantoin |
WO2009011261A1 (en) | 2007-07-19 | 2009-01-22 | Tokuyama Corporation | Compound having hydantoin ring and method of producing the same |
EP2280941B1 (en) * | 2008-03-27 | 2015-05-06 | Grünenthal GmbH | (hetero-)aryl cyclohexane derivatives |
KR20120075500A (en) | 2008-03-27 | 2012-07-06 | 그뤼넨탈 게엠베하 | Substituted 4-aminocyclohexane derivatives |
WO2009152079A1 (en) | 2008-06-09 | 2009-12-17 | Palatin Technologies, Inc. | Melanocortin receptor-specific peptides for treatment of sexual dysfunction |
AR072072A1 (en) * | 2008-06-09 | 2010-08-04 | Palatin Technologies Inc | SPECIFIC PEPTIDES OF THE MELANOCORTINE RECEPTOR FOR THE TREATMENT OF OBESITY / 669 |
KR101726893B1 (en) | 2009-06-08 | 2017-04-13 | 팔라틴 테크놀로지스 인코포레이티드 | Melanocortin receptor-specific peptides |
UY32690A (en) | 2009-06-08 | 2011-01-31 | Astrazeneca Ab | SPECIFIC PEPTIDES FOR MELANOCORTIN RECEPTORS |
WO2010144341A2 (en) | 2009-06-08 | 2010-12-16 | Palatin Technologies, Inc. | Lactam-bridged melanocortin receptor-specific peptides |
MX2012005862A (en) | 2009-11-23 | 2012-09-07 | Palatin Technologies Inc | Melanocortin-1 receptor-specific cyclic peptides. |
EP2504351A4 (en) | 2009-11-23 | 2013-10-30 | Palatin Technologies Inc | Melanocortin-1 receptor-specific linear peptides |
CN118240012A (en) * | 2013-03-15 | 2024-06-25 | 节奏制药公司 | Peptide composition |
GB201416352D0 (en) | 2014-09-16 | 2014-10-29 | Shire Internat Gmbh | Spirocyclic derivatives |
GB201416351D0 (en) * | 2014-09-16 | 2014-10-29 | Shire Internat Gmbh | Heterocyclic derivatives |
EA201790699A1 (en) * | 2014-09-26 | 2017-10-31 | Байер Фарма Акциенгезельшафт | STABILIZED DERIVATIVES OF ADRENOMEDULLINE AND THEIR APPLICATION |
WO2017066754A1 (en) | 2015-10-15 | 2017-04-20 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Compositions and methods for the treatment of depression and anxiety |
US11542302B2 (en) | 2015-10-15 | 2023-01-03 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Modulators of melanocortin receptors for the treatment of depression and anxiety |
US10899793B2 (en) | 2016-05-27 | 2021-01-26 | Regents Of The University Of Minnesota | Melanocortin ligands and methods of use thereof |
US20190255142A1 (en) * | 2016-10-17 | 2019-08-22 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Novel modulators of melanocortin receptors for the treatment of depression and anxiety |
US11124541B2 (en) | 2016-10-18 | 2021-09-21 | Regents Of The University Of Minnesota | Chimeric melanocortin ligands and methods of use thereof |
CN106496005B (en) * | 2016-10-20 | 2019-04-09 | 上海毕得医药科技有限公司 | A kind of synthetic method of 4- (4- chlorphenyl) cyclohexanone |
CN106496008A (en) * | 2016-10-20 | 2017-03-15 | 上海毕得医药科技有限公司 | A kind of method of synthesis 4 (4 chlorphenyl) cyclohexanone |
US10745444B2 (en) * | 2017-04-17 | 2020-08-18 | National Tsing Hua University | Cyclopeptide, pharmaceutical or cosmetic composition comprising the same and method for preparing the same |
US11332499B2 (en) | 2018-08-16 | 2022-05-17 | Regents Of The University Of Minnesota | Cyclic peptides and methods of use thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5811391A (en) | 1994-08-25 | 1998-09-22 | Cytel Corporation | Cyclic CS-1 peptidomimetics, compositions and methods of using same |
US5858972A (en) | 1996-01-11 | 1999-01-12 | La Jolla Cancer Research Foundation | Antithrombotic agents and methods of use |
KR100558131B1 (en) | 1999-03-29 | 2006-03-10 | 더 프록터 앤드 갬블 캄파니 | A pharmaceutical composition comprising melanocortin receptor ligands and a manufacture of a medicament comprising melanocornin receptor ligands |
-
2001
- 2001-08-21 PT PT01962958T patent/PT1315750E/en unknown
- 2001-08-21 KR KR10-2003-7002931A patent/KR100483300B1/en not_active IP Right Cessation
- 2001-08-21 AU AU8402601A patent/AU8402601A/en active Pending
- 2001-08-21 IL IL15457501A patent/IL154575A0/en unknown
- 2001-08-21 CN CNB018150284A patent/CN100491396C/en not_active Expired - Fee Related
- 2001-08-21 DE DE60126624T patent/DE60126624T2/en not_active Expired - Lifetime
- 2001-08-21 CA CA002420058A patent/CA2420058C/en not_active Expired - Fee Related
- 2001-08-21 AT AT01962958T patent/ATE353918T1/en active
- 2001-08-21 CZ CZ2003584A patent/CZ2003584A3/en unknown
- 2001-08-21 PL PL01366630A patent/PL366630A1/en not_active Application Discontinuation
- 2001-08-21 DK DK01962958T patent/DK1315750T3/en active
- 2001-08-21 YU YU15603A patent/YU15603A/en unknown
- 2001-08-21 ES ES01962958T patent/ES2280393T3/en not_active Expired - Lifetime
- 2001-08-21 SI SI200130703T patent/SI1315750T1/en unknown
- 2001-08-21 RU RU2003107921/04A patent/RU2239642C1/en not_active IP Right Cessation
- 2001-08-21 WO PCT/EP2001/009630 patent/WO2002018437A2/en active IP Right Grant
- 2001-08-21 MX MXPA03001721A patent/MXPA03001721A/en active IP Right Grant
- 2001-08-21 AU AU2001284026A patent/AU2001284026B2/en not_active Ceased
- 2001-08-21 EP EP01962958A patent/EP1315750B1/en not_active Expired - Lifetime
- 2001-08-21 JP JP2002523951A patent/JP4217069B2/en not_active Expired - Fee Related
- 2001-08-21 NZ NZ523989A patent/NZ523989A/en unknown
- 2001-08-21 BR BR0113637-2A patent/BR0113637A/en not_active IP Right Cessation
- 2001-08-21 HU HU0303078A patent/HUP0303078A3/en unknown
- 2001-08-23 JO JO2001138A patent/JO2454B1/en active
- 2001-08-27 US US09/939,966 patent/US7045591B2/en not_active Expired - Fee Related
- 2001-08-28 MY MYPI20014025A patent/MY137457A/en unknown
- 2001-08-28 PA PA20018527201A patent/PA8527201A1/en unknown
- 2001-08-28 PE PE2001000859A patent/PE20020483A1/en not_active Application Discontinuation
- 2001-08-28 AR ARP010104096A patent/AR030504A1/en active IP Right Grant
- 2001-08-30 TW TW090121400A patent/TWI248941B/en not_active IP Right Cessation
-
2003
- 2003-02-05 ZA ZA200301015A patent/ZA200301015B/en unknown
- 2003-02-20 HR HR20030126A patent/HRP20030126B1/en not_active IP Right Cessation
- 2003-02-20 IL IL154575A patent/IL154575A/en not_active IP Right Cessation
- 2003-02-27 MA MA27059A patent/MA27681A1/en unknown
- 2003-02-27 NO NO20030916A patent/NO20030916L/en not_active Application Discontinuation
- 2003-03-06 EC EC2003004503A patent/ECSP034503A/en unknown
-
2007
- 2007-05-07 CY CY20071100594T patent/CY1106562T1/en unknown
- 2007-05-30 AR ARP070102336A patent/AR061422A2/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2003107921A (en) | SELECTIVE CYCLOPEPTIDES | |
JP6937090B2 (en) | 1,2,4-oxadiazole and thiadiazole compounds as immunomodulators | |
KR102362277B1 (en) | 1,2,4-oxadiazole derivatives as immunomodulators | |
RU2218919C2 (en) | Heterocyclic vinyl esters eliciting activity with respect to neurological diseases | |
EP1862458A3 (en) | Therapeutic agents useful for treating pain | |
JP2003506354A5 (en) | ||
JP2005524628A5 (en) | ||
RU97107338A (en) | NEW COMPOUNDS | |
HUP0300121A2 (en) | Macrocyclic peptides active against the hepatitis c virus, process for preparation and pharmaceutical compositions containing them | |
RU2003130058A (en) | COMBINATIONS INCLUDING ANTIDIARAH AGENT AND EPOTHYLON OR EPOTHYLON DERIVATIVES | |
RU2004109812A (en) | 2-cyano-4-aminopyrimidine cysteine protease inhibitors with an inhibitory effect on cathepsin K for the treatment of inflammatory and other diseases | |
JP2001512743A5 (en) | ||
JP2003522198A5 (en) | ||
JP2002519425A5 (en) | ||
JP2002520282A5 (en) | ||
RU2331425C2 (en) | Pharmaceutical compositions and methods, that include combinations of 2-alkyldien-19-nor-vitamin d derivatives and estrogens agonist/antagonist | |
TW200517127A (en) | Novel composition | |
US6509330B2 (en) | Hydroxamic acid containing compounds useful as ACE inhibitors and/or NEP inhibotors | |
RU2002125463A (en) | The polypeptide compound, methods for its preparation, pharmaceutical composition and method for the prevention or treatment of fungal diseases | |
RU2008137533A (en) | ORGANIC COMPOUNDS | |
EP1078635A3 (en) | Medicaments comprising sialic acid derivatives as active ingredients | |
RU2004116067A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING MACROLIDES | |
RU2023136077A (en) | IDH MUTANT INHIBITOR AND ITS APPLICATION | |
RU97113700A (en) | APPLICATION OF 3,4-DIPHENYLCHROMANES FOR OBTAINING A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF OBESITY | |
CN112773802A (en) | Application of compound in preventing or treating graft-versus-host disease |